hVIVO (HVO) Competitors GBX 10.85 +0.60 (+5.85%) As of 08/8/2025 11:57 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesBuy This Stock HVO vs. FARN, VRP, AVCT, ARIX, CIR, BVXP, 4BB, TILS, VSN, and SCLPShould you be buying hVIVO stock or one of its competitors? The main competitors of hVIVO include Faron Pharmaceuticals Oy (FARN), Verona Pharma plc (VRP.L) (VRP), Avacta Group (AVCT), Arix Bioscience (ARIX), Circassia Group (CIR), Bioventix (BVXP), 4basebio (4BB), Tiziana Life Sciences (TILS), Verseon (VSN), and Scancell (SCLP). These companies are all part of the "biotechnology" industry. hVIVO vs. Its Competitors Faron Pharmaceuticals Oy Verona Pharma plc (VRP.L) Avacta Group Arix Bioscience Circassia Group Bioventix 4basebio Tiziana Life Sciences Verseon Scancell hVIVO (LON:HVO) and Faron Pharmaceuticals Oy (LON:FARN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Does the media favor HVO or FARN? In the previous week, Faron Pharmaceuticals Oy had 4 more articles in the media than hVIVO. MarketBeat recorded 4 mentions for Faron Pharmaceuticals Oy and 0 mentions for hVIVO. hVIVO's average media sentiment score of 0.00 beat Faron Pharmaceuticals Oy's score of -0.26 indicating that hVIVO is being referred to more favorably in the media. Company Overall Sentiment hVIVO Neutral Faron Pharmaceuticals Oy Neutral Which has higher valuation and earnings, HVO or FARN? hVIVO has higher revenue and earnings than Faron Pharmaceuticals Oy. Faron Pharmaceuticals Oy is trading at a lower price-to-earnings ratio than hVIVO, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiohVIVO£68.74M1.12£17.84M£2.424.48Faron Pharmaceuticals OyN/AN/A-£60.23M-£37.39-5.88 Which has more risk & volatility, HVO or FARN? hVIVO has a beta of 0.97, indicating that its share price is 3% less volatile than the S&P 500. Comparatively, Faron Pharmaceuticals Oy has a beta of 0.36, indicating that its share price is 64% less volatile than the S&P 500. Do institutionals and insiders believe in HVO or FARN? 34.9% of hVIVO shares are owned by institutional investors. Comparatively, 10.7% of Faron Pharmaceuticals Oy shares are owned by institutional investors. 14.0% of hVIVO shares are owned by company insiders. Comparatively, 31.8% of Faron Pharmaceuticals Oy shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Do analysts prefer HVO or FARN? hVIVO currently has a consensus target price of GBX 28, indicating a potential upside of 158.06%. Given hVIVO's stronger consensus rating and higher possible upside, equities research analysts clearly believe hVIVO is more favorable than Faron Pharmaceuticals Oy.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score hVIVO 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Faron Pharmaceuticals Oy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is HVO or FARN more profitable? hVIVO has a net margin of 25.96% compared to Faron Pharmaceuticals Oy's net margin of 0.00%. hVIVO's return on equity of 47.93% beat Faron Pharmaceuticals Oy's return on equity.Company Net Margins Return on Equity Return on Assets hVIVO25.96% 47.93% 11.97% Faron Pharmaceuticals Oy N/A 0.46%-70.00% SummaryhVIVO beats Faron Pharmaceuticals Oy on 13 of the 15 factors compared between the two stocks. Get hVIVO News Delivered to You Automatically Sign up to receive the latest news and ratings for HVO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HVO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HVO vs. The Competition Export to ExcelMetrichVIVOBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£76.77M£134.73M£5.44B£3.07BDividend Yield1.10%3.74%4.61%5.03%P/E Ratio4.483.7929.75170.63Price / Sales1.124,344.35449.48303,754.90Price / Cash4.9413.1936.4227.96Price / Book1.9538.648.184.52Net Income£17.84M-£90.30M£3.26B£5.90B7 Day Performance8.50%1.98%6.87%1.23%1 Month Performance3.33%3.92%0.99%3.62%1 Year Performance-62.78%193.72%28.84%58.36% hVIVO Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HVOhVIVON/AGBX 10.85+5.9%GBX 28+158.1%-62.5%£76.77M£68.74M4.48N/ANews CoverageGap UpFARNFaron Pharmaceuticals OyN/AGBX 197+1.0%N/A+25.4%£264.48MN/A-5.2734News CoverageGap UpVRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpAVCTAvacta GroupN/AGBX 53.14-2.5%N/A-36.4%£201.89M£26.29M-6.84120News CoverageGap UpHigh Trading VolumeARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.919CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownBVXPBioventixN/AGBX 2,650-0.9%N/A-45.3%£138.76M£13.65M17.1412Positive News4BB4basebio1.9707 of 5 starsGBX 943-2.8%GBX 1,600+69.7%-29.3%£120.80M£311K-1,208.97101TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpSCLPScancellN/AGBX 9.68-0.7%N/A-36.3%£100.26MN/A-14.8451News CoverageInsider Trade Related Companies and Tools Related Companies FARN Competitors VRP Competitors AVCT Competitors ARIX Competitors CIR Competitors BVXP Competitors 4BB Competitors TILS Competitors VSN Competitors SCLP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HVO) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFOUR TRILLION DOLLARS!Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft....Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding hVIVO plc Please log in to your account or sign up in order to add this asset to your watchlist. Share hVIVO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
